Intl Isotopes Files 8-K: Officer/Director Changes & Bylaw Amendments

TL;DR

INIS leadership shakeup, bylaws tweaked, financials filed.

AI Summary

International Isotopes Inc. filed an 8-K on October 17, 2025, reporting events as of October 10, 2025. The filing indicates changes related to the departure of directors or officers, election of directors, appointment of officers, and compensatory arrangements. It also covers amendments to articles of incorporation or bylaws and changes in the fiscal year, along with financial statements and exhibits.

Why It Matters

This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.

Risk Assessment

Risk Level: medium — Changes in directors, officers, and bylaws can indicate internal shifts that may affect future performance or strategy.

Key Numbers

• 20251010 — Event Date (Date of earliest event reported)
• 20251017 — Filing Date (Date the report was filed with the SEC)

Key Players & Entities

• INTERNATIONAL ISOTOPES INC. (company) — Registrant
• Texas (jurisdiction) — State of incorporation
• 74-2763837 (company_id) — I.R.S. Employer Identification No.
• 4137 Commerce Circle Idaho Falls, ID 83401 (address) — Principal Executive Offices
• 208 - 524-5300 (phone_number) — Business Phone

FAQ

Key Financial Figures

• $314,000 — alary under the Employment Agreement is $314,000 per year as of July 18, 2025, with annu
• $50,000 — djian is eligible to receive additional $50,000 increases to his annual base salary bas
• $3.75 million — rly revenue hits each of the following: $3.75 million; $6.25 million; $12.5 million; $18.75 m
• $6.25 million — s each of the following: $3.75 million; $6.25 million; $12.5 million; $18.75 million; and $25
• $12.5 million — ollowing: $3.75 million; $6.25 million; $12.5 million; $18.75 million; and $25 million. In a
• $18.75 million — million; $6.25 million; $12.5 million; $18.75 million; and $25 million. In addition to his s
• $25 million — ion; $12.5 million; $18.75 million; and $25 million. In addition to his salary, each year
• $0.10 — ,000 RSUs will vest at a share price of $0.10; 5,000,000 RSUs will vest at a share pr
• $0.15 — ,000 RSUs will vest at a share price of $0.15; 7,500,000 RSUs will vest at a share pr
• $0.20 — ,000 RSUs will vest at a share price of $0.20; 10,000,000 RSUs will vest at a share p
• $0.25 — ,000 RSUs will vest at a share price of $0.25; and 12,500,000 RSUs will vest at a sha
• $0.30 — ,000 RSUs will vest at a share price of $0.30. Mr. Bagerdjian was previously awarded

Filing Documents

• inis20251016_8k.htm (8-K) — 45KB
• ex_871446.htm (EX-3.1) — 134KB
• ex_871447.htm (EX-10.1) — 194KB
• 0001437749-25-031241.txt ( ) — 570KB
• inis-20251010.xsd (EX-101.SCH) — 3KB
• inis-20251010_def.xml (EX-101.DEF) — 10KB
• inis-20251010_lab.xml (EX-101.LAB) — 14KB
• inis-20251010_pre.xml (EX-101.PRE) — 11KB
• inis20251016_8k_htm.xml (XML) — 3KB

03 Amendments to Articles of Incorporation or Bylaws; Change

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change. On October 14, 2025, the Board approved changes to the Company's bylaws (the "Bylaws"), which are summarized below, and which are attached in full as an exhibit hereto. Section 2.02 of the Bylaws regarding "Special Meetings" was revised to clarify that no business may be transacted at a special meeting other than the business specified in the notice to shareholders. In addition, Section 2.02 now also provides that the Company may postpone, reschedule or cancel any special meeting of shareholders previously scheduled by the chairman of the Board or by the secretary of the Company upon direction from the Board. A new Section 2.04 was added regarding "Advance Notice Procedures for Business Brought Before a Meeting" and a new Section 2.05 was added regarding "Advance Notice Procedures for Nominations of Directors," and the numbering of subsequent Article Two sections have been adjusted accordingly. Section 2.04 provides that at an annual meeting of shareholders, only business that has been properly brought before the meeting will be conducted and sets forth the way to provide timely and proper notice. Section 2.05 provides the procedures for which a nomination to the Board must be submitted, and specifies that Board nominees may only be at the direction of the Board or any committee or persons authorized to do so by the Board or the Bylaws, or by a shareholder present in person who was a beneficial owner of shares of the Company both at the time of giving the notice provided for in Section 2.05 and at the time of the meeting, who is entitled to vote at the meeting and who has otherwise complied with the provisions Section 2.05 as to such notice and nomination requirements. A new Section 3.14 was added permitting the Board to appoint advisory directors to serve as consultants to the Board based upon their business or technical expertise and on such terms as the Board deems appropriate. Any advisory

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 3.1 Amended and Restated Bylaws of International Isotopes Inc., effective as of October 14, 2025. 10.1 Executive Employment Agreement, dated October 10, 2025, between the Company and Shahe Bagerdjian. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 17, 2025 INTERNATIONAL ISOTOPES INC. By: /s/ Shahe Bagerdjian Name: Shahe Bagerdjian Title: President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR